Answer
Letermovir is not recommended during pregnancy or in women of childbearing potential not using contraception, because there are no data in pregnant women and animal studies have shown reproductive toxicity.
Sources for this answer
- PREVYMIS 240 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 14Document updated
Sources checked